The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.
This Laughter Yoga teacher explains the power of the breath in our health and healing.
What you do matters, even in the waiting room of the oncologist's office.
In a recent survey, researchers from the University of Colorado Denver found a variety of predictors that affect caregiver burden, and how psychological resilience and future interventions can help.
Words I use to describe myself include "survivor, activist, teacher, superhero geek and cat dad." Inspiration? Not a word in my top ten.
Five leading cancer organizations came together to establish four steps that patients of all malignancies can turn to as they navigate their experience.
How do you stay positive when surrounded by death and dying?
PARP inhibitors have made for new and exciting treatment options for ovarian cancer, but there is still much more work to be done, according to Dennis J. Slamon, M.D., Ph.D.
An Extraordinary Healer essay honoring JENNI CHANG, B.S.N., RN, OCN [VA PALO ALTO HEALTH CARE SYSTEM, PALO ALTO, CALIFORNIA]
As the field of lung cancer continues to evolve, here are some of the key discussions patients should have with their health care team, according to one expert.
Summertime presents challenges for women affected by breast cancer. Body image often suffers if a woman hasn't come to terms with her new appearance.
Since its classification in 1994, the prognosis for patients diagnosed with mantle cell lymphoma (MCL) was generally poor; however, survival rates have nearly doubled thanks to improvements in the treatment landscape over the past 10 years.
How we imagine our future may influence our health and healing.
Robert Louis Stevenson's poem, "My Shadow" reminds this cancer survivor about her diagnosis.
Breast cancer and melanoma survivor reflects on recovering from her cancer experiences.
While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.
I'm learning to expect scanxiety, and that helped keep it at bay.
Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.
A look at how one cancer survivor has witnessed life-changing medical advancements over the years.
While there has been no hard evidence that exercise can improve survival in patients with cancer, it can boost patients' mood and how they feel.
The American Cancer Society issued an updated guideline recommendation that now calls for screening to begin at age 45 for individuals at average risk for colorectal cancer.
Understanding one’s biomarkers, such as microsatellite stable (MSS) or instable (MSI) status in tumors, is key in understanding how a patient with colorectal cancer may be treated.
I laughed after I put my soiled laundry in the wastepaper bin in my bathroom instead of the laundry hamper. When I told my oncologist, she didn’t think it was funny at all.
When my mom got cancer, the last thing on my mind was my own health, but she had the foresight and the care to get a genetic test so that her kids could live long and healthy lives. Today I am grateful for my mom, my whole family and the magic of science.
Take a look at the top five CURE stories of June 2018 in this video.
The Food and Drug Administration (FDA) granted a priority review to Keytruda (pembrolizumab) in combination with chemotherapy as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC), regardless of PD-L1 expression, according to Merck, the manufacturer of the anti-PD-1 agent.
Is it too much to want to feel like myself again after cancer?
Five techniques to help you when "wait and see" is the only option
PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.
Because little is known about the effect of patients' sex on the efficacy of immune checkpoint inhibitors as cancer treatments, the researchers performed a systematic review and meta-analysis to determine the heterogeneity of immune checkpoint inhibitor efficacy between men and women.
